ADVISE Trademark

Trademark Overview

On Wednesday, August 7, 2019, a trademark application was filed for ADVISE with the United States Patent and Trademark Office. The USPTO has given the ADVISE trademark a serial number of 88570207. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 25, 2022. This trademark is owned by Arena Pharmaceuticals, Inc.. The ADVISE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Conducting clinical trials for others
advise

General Information

Serial Number88570207
Word MarkADVISE
Filing DateWednesday, August 7, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 25, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 29, 2019

Trademark Statements

Goods and ServicesConducting clinical trials for others

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, August 24, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameArena Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameArena Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Monday, July 25, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 25, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, May 27, 2022ASSIGNED TO EXAMINER
Tuesday, January 25, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 25, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, December 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 2, 2021SOU EXTENSION 4 GRANTED
Thursday, December 2, 2021SOU EXTENSION 4 FILED
Thursday, December 2, 2021TEAS EXTENSION RECEIVED
Thursday, June 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 22, 2021SOU EXTENSION 3 GRANTED
Tuesday, June 22, 2021SOU EXTENSION 3 FILED
Tuesday, June 22, 2021TEAS EXTENSION RECEIVED
Tuesday, December 15, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 11, 2020SOU EXTENSION 2 GRANTED
Friday, December 11, 2020SOU EXTENSION 2 FILED
Friday, December 11, 2020TEAS EXTENSION RECEIVED
Saturday, June 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 11, 2020SOU EXTENSION 1 GRANTED
Thursday, June 11, 2020SOU EXTENSION 1 FILED
Thursday, June 11, 2020TEAS EXTENSION RECEIVED
Tuesday, December 24, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 29, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 29, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 9, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 19, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 18, 2019ASSIGNED TO EXAMINER
Monday, August 26, 2019PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Saturday, August 24, 2019ASSIGNED TO LIE
Saturday, August 24, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 15, 2019TEAS VOLUNTARY AMENDMENT RECEIVED
Saturday, August 10, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

advise others trials clinical conducting